title: Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment.
abstract: Sulpiride (SUL, 20 mg kg-1 day-1) induces weight gain, hyperphagia, hyperprolactinemia, hypogonadism, and perhaps increased insulin sensitivity in rats. Leptin seems to signal the brain about the size of body fat stores and nutrient metabolism. We evaluated the basal serum leptin levels in rats after acute (1 h) or prolonged SUL or vehicle administration (10, 20 and 30 days). At days 10 and 30 leptin was also assessed during a glucose overload test. As the maximal weight gain during SUL administration is observed at days 10-15 of treatment, leptin was measured in a comparison group of insulin-treated rats (5 IU day-1 for 10 days). SUL-treated rats significantly gained weight. However, leptin levels were not significantly increased at any time-point of treatment. SUL did not affect insulin levels either. By contrast, leptin levels were significantly elevated after insulin administration, along with weight gain and hyperinsulinemia. An opposite correlation was also observed at day 10: leptin and insulin correlated negatively in the SUL group and positively in the insulin group. In addition, leptin and the magnitude of weight gain tended to correlate positively after SUL treatment, but negatively after insulin administration. SUL-treated rats, thus, appear to exhibit an unusual type of weight gain, characterized by normal circulating leptin and insulin levels. Such a particular leptin profile may be related to hyperprolactinemia, hypogonadism or lack of hyperinsulinemia. Molecular Psychiatry (2000) 5, 70-76.
authors.affiliation: Laboratory of Behavioral Physiology, School of Medicine, University of Los Andes, Mérida, Venezuela.
authors.forename: A
authors.initials: A
authors.lastname: Lacruz
authors.forename: T
authors.initials: T
authors.lastname: Baptista
authors.forename: S
authors.initials: S
authors.lastname: de Mendoza
authors.forename: J M
authors.initials: JM
authors.lastname: Mendoza-Guillén
authors.forename: L
authors.initials: L
authors.lastname: Hernández
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001786:Blood Glucose; D005260:Female; D005951:Glucose Tolerance Test; D007328:Insulin / Q000097:blood*; D020738:Leptin / Q000097:blood*; D015999:Multivariate Analysis; D009765:Obesity / Q000139:chemically induced*; D051381:Rats; D017208:Rats, Wistar; D013469:Sulpiride / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D013469:Sulpiride